drug reps are suggesting that Actonel (risedronate) causes fewer GI side effects than Fosamax (alendronate)
August 2003
Some drug reps are suggesting that Actonel (risedronate) causes fewer GI side effects than Fosamax (alendronate).
It's true that some comparisons show a potential advantage to Actonel. But there are also studies showing no difference.
Most of the research is company-sponsored. It's no surprise that results tend to favour the sponsoring company's drug.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter Canada includes:
- 12 issues every year, with brief articles about new meds and hot topics
- 200+ CE courses, including the popular CE-in-the-Letter
- Quick reference drug comparison charts
- Access to the entire archive